JPMorgan Upgrades Integra LifeSciences (IART) to Overweight
Tweet
Share
E-mailGet Alerts IART Hot Sheet
Price: $15.59 +2.43%
Rating Summary:
8 Buy, 17 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 3 | Down: 3 | New: 5
Rating Summary:
8 Buy, 17 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 3 | Down: 3 | New: 5
Join SI Premium – FREE
JPMorgan upgraded Integra LifeSciences (NASDAQ: IART) from Neutral to Overweight with a price target of $80.00.
For an analyst ratings summary and ratings history on Integra LifeSciences click here. For more ratings news on Integra LifeSciences click here.
Shares of Integra LifeSciences closed at $64.00 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Kepler Cheuvreux Upgrades Shaftesbury Capital PLC (SHC:LN) to Hold
- RBC Capital Upgrades Telix Pharmaceuticals Ltd (TLX:AU) (TLX) to Outperform
- Citizens Upgrades Quince Therapeutics Inc. (QNCX) to Market Outperform
Create E-mail Alert Related Categories
UpgradesRelated Entities
JPMorganSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
